DOCSLIB.ORG

Genetic Basis of Metabolic Evolution in the Cave Fish Astyanax Mexicanus

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Genetic Basis of Metabolic Evolution in the Cave Fish Astyanax Mexicanus Genetic Basis of Metabolic Evolution in the Cave Fish Astyanax Mexicanus The Harvard community has made this article openly available. Please share how this access benefits you. Your story matters Citable link http://nrs.harvard.edu/urn-3:HUL.InstRepos:40050145 Terms of Use This article was downloaded from Harvard University’s DASH repository, and is made available under the terms and conditions applicable to Other Posted Material, as set forth at http:// nrs.harvard.edu/urn-3:HUL.InstRepos:dash.current.terms-of- use#LAA Gene�c Basis of Metabolic Evolu�on in the Cave fish Astyanax mexicanus A disserta�on presented by Ariel Cacayuran Aspiras to The Division of Medical Sciences in par�al fulfillment of the requirements for the degree of Doctor of Philosophy in the subject of Biological and Biomedical Sciences Harvard University Cambridge, Massachuse�s May 2018 ©2018 by Ariel Cacayuran Aspiras All rights reserved. iii Dissertation Advisor: Dr. Clifford Tabin Ariel Cacayuran Aspiras Genetic Basis of Metabolic Evolution in the Cave fish Astyanax mexicanus Abstract Organisms evolve to thrive in new environments. In spite of the role metabolism plays in adaptation, the genetic basis for metabolic variation remains poorly understood. Here we use independently derived populations of Astyanax mexicanus, a Mexican tetra, to interrogate the genetic basis of extreme metabolic variation between surface and cave adapted populations. In the cave environment, food is much more scarce than in nutrient-rich rivers. Cave populations of Astyanax mexicanus rely on sporadic input of food from outside the cave. As a result, cave fish populations have evolved a suite of metabolic traits such as: starvation resistance, hyperphagia, hyperglycemia, and insulin resistance. We examined starvation resistance and hyperphagia in cave fish, finding that all cave populations had elevated triglycerides and reduced weight loss while fasting. Intriguingly, only a subset of the cave populations exhibited hyperphagia. Using a candidate gene approach, we identified a conserved coding mutation in melanocortin 4 receptor (mc4r), specific to hyperphagic populations. A comparison of signaling efficiency demonstrate that the cave allele had reduced maximal response and reduced basal activity relative to the surface allele in vitro. We further show that the cave allele contributes to hyperphagia and starvation resistance in vivo. We also investigated variation in blood glucose regulation among cave and surface populations. We observed a dysregulation in blood glucose homeostasis and insulin resistance in a subset of cave populations. Those populations were carrying a mutation in insulin receptor that leads to reduced ligand binding in vitro and contributes to elevated blood glucose. Surface/cave hybrids carrying the allele are heavier than non-carriers and zebrafish genetically iv engineered with the cave allele are heavier and insulin resistant. Humans with an identical mutation have a severe form of insulin resistance and reduced life span. However, cave fish populations with this mutation have a similar life span to surface counterparts and do not accumulate advanced glycation end products typically associated with the progression of diabetes-associated pathologies. Together, these studies provide new insight on how complex metabolic systems such blood glucose and weight regulation evolve and vary among populations. v Table of Contents Abstract ........................................................................................................................................................ iii Acknowledgements ...................................................................................................................................... vi Dedication .................................................................................................................................................. viii Chapter 1 Introduction ................................................................................................................................. 1 Summary: .................................................................................................................................................. 2 Metabolic evolution: ................................................................................................................................. 2 The Cave fish System ................................................................................................................................ 7 Overview of the dissertation: ................................................................................................................. 10 Works Cited ............................................................................................................................................. 12 Chapter 2 melanocortin 4 receptor ............................................................................................................. 21 Abstract ................................................................................................................................................... 23 Introduction ............................................................................................................................................ 24 Results ..................................................................................................................................................... 25 Discussion................................................................................................................................................ 34 Works Cited ............................................................................................................................................. 38 Materials and Methods: .......................................................................................................................... 41 Chapter 3 insulin receptor ........................................................................................................................... 44 Methods .................................................................................................................................................. 59 Works Cited ............................................................................................................................................. 67 Chapter 4 Concluding Discussion ................................................................................................................ 70 Appendix 1: QTL on blood glucose.............................................................................................................. 81 Appendix 2: Chapter 2 supplemental data ................................................................................................. 96 Appendix 3: Chapter 3 extra data ............................................................................................................. 111 vi Acknowledgements I would not be here today without my mom, Rose Aspiras and my guardians, Michael and Eileen Harte. My mom emigrated from the Philippines when I was 2 to work as nurse. When I was 5, she brought me to United States, so that I could be raised in the land of opportunity. My mom worked at least two fulltime jobs to provide for me and for her family back in the Philippines. When I was 9, she passed away. I would have been sent back, but Michael and Eileen took me in and raised me. They were friends with my mom and had babysat for me in the past. But in truth, none of us were prepared for the challenges that awaited us. They had just sent their son James to college and were ready to have the nest be empty. Yet, they took me in anyways and raised me as one of their own. I’m eternally grateful to all three of my parents. I owe my love for scientific research to Dr. David Angelini. Dr. A is a smart, generous and patient mentor. He gave me confidence in my work and allowed me to explore any questions I found interesting. I need to also thank Dr. David Carlini and Dr. Daniel Fong from American University. They taught me how to be critical of my work, how to present my data, and the value of collaboration. I owe my love for cave biology to Dr. Fong. He took me caving, which initiated a collaborative side project with Dr. A. He also invited me to the weekly cave club margarita meetings with the premier D.C. area cave biologists Dr. David Culver and Dr. Bill Jeffery. Dr. A, Dr. Carlini and Dr. Fong all took an interest in me and went above and beyond what a mentor had to do. I wouldn’t have made it to Harvard without them. I knew I wanted to join Dr. Clifford Tabin’s lab well before my first rotation. While I was applying for PhD programs, I saw him give a talk at a Society of Developmental Biology meeting, when he was receiving a mentorship award. I just remember feeling amazed by his talk and feeling like I just wanted vii to be a part of his team. I’m so grateful that he allowed me to join his lab. Cliff has been such a generous and supportive mentor to me and I will miss being in his lab. I am also grateful to my DAC members, Dr. Matt Harris, Dr. Spiegelman, Dr. David Reich, and Dr. Naar. They have always provided me with great feedback and council. One of the key strengths of Cliff and Dr. Connie Cepko’s lab is its people. I am so thankful that I have spent my PhD surrounded by the most generous, intelligent lab mates. I want to especially thank Yash, Brian M, Brian R, Tyler K, Tyler H, Cem, John D, Megan, and Gene for being there to talk science
Load more

Recommended publications
  • Are Zinc Transporter Type 8 Antibodies a Marker of Autoimmune Thyroiditis in Non-Obese Adults with New-Onset Diabetes?
    A Rogowicz-Frontczak and ZnT8A are associated with ATPO 170:4 651–658 Clinical Study others in diabetes Are zinc transporter type 8 antibodies a marker of autoimmune thyroiditis in non-obese adults with new-onset diabetes? Anita Rogowicz-Frontczak1, Dorota Zozulin´ ska-Zio´ łkiewicz1, Monika Litwinowicz2, Paweł Niedz´wiecki1, Krystyna Wyka3 and Bogna Wierusz-Wysocka1 Correspondence should be addressed to Departments of 1Internal Medicine and Diabetology and 2Internal Diseases, Metabolic Disorders and Dietetics, A Rogowicz-Frontczak Poznan University of Medical Sciences, Mickiewicza 2, 60-834 Poznan, Poland and 3Medical University of Lodz, Email Lodz, Poland [email protected] Abstract Objective: The diagnosis of autoimmune diabetes in non-obese adults is based on the detection of glutamic acid decarboxylase autoantibodies (GADA), islet cell antibodies (ICA) and antibodies to tyrosine phosphatase (IA-2A). Zinc transporter 8 (ZnT8) has been identified as a new autoantigen in patients with type 1 diabetes mellitus. The coincidence of autoimmune thyroiditis (AITD) with diabetes is common; therefore, screening of TSH and thyroid peroxidase antibodies (ATPO) is recommended during the diagnosis of diabetes. In this study, we determined whether the occurrence of islet autoantibodies is associated with a positive titre of ATPO in newly diagnosed adult-onset autoimmune diabetic patients. Design and methods: The study involved 80 non-obese adults aged 44 (interquartile range (IQR): 37–51) years with a BMI of 24.0 (IQR: 22.2–26.0) kg/m2 and new-onset diabetes. The markers of autoimmune diabetes (GADA, ICA, IA-2A and ZnT8A), TSH and thyroid peroxidase antibodies (ATPO) were evaluated. Results: In the study population, 70% (nZ56) of the subjects were positive for at least one of the four assessed markers of autoimmune diabetes (83.9% GADA, 62.5% ICA, 42.8% IA-2A and 33% ZnT8A) and 37.5% of the subjects were positive for ATPO.
    [Show full text]
  • A Consensus Report from the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD)
    Diabetologia https://doi.org/10.1007/s00125-020-05181-w CONSENSUS REPORT Precision medicine in diabetes: a Consensus Report from the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD) Wendy K. Chung1,2 & Karel Erion3 & Jose C. Florez4,5,6,7,8 & Andrew T. Hattersley9 & Marie-France Hivert5,10 & Christine G. Lee11 & Mark I. McCarthy12,13,14 & John J. Nolan15 & Jill M. Norris16 & Ewan R. Pearson17 & Louis Philipson 18,19 & Allison T. McElvaine20 & William T. Cefalu11 & Stephen S. Rich21,22 & Paul W. Franks23,24 # European Association for the Study of Diabetes and American Diabetes Association 2020 Abstract The convergence of advances in medical science, human biology, data science and technology has enabled the generation of new insights into the phenotype known as ‘diabetes’. Increased knowledge of this condition has emerged from popu- lations around the world, illuminating the differences in how diabetes presents, its variable prevalence and how best practice in treatment varies between populations. In parallel, focus has been placed on the development of tools for the application of precision medicine to numerous conditions. This Consensus Report presents the American Diabetes Association (ADA) Precision Medicine in Diabetes Initiative in partnership with the European Association for the Study of Diabetes (EASD), including its mission, the current state of the field and prospects for the future. Expert opinions are presented on areas of precision diagnostics and precision therapeutics (including prevention and treatment) and key barriers to and opportunities for implementation of precision diabetes medicine, with better care and outcomes around the globe, are highlighted. Cases where precision diagnosis is already feasible and effective (i.e.
    [Show full text]
  • Mestrado Thais Cristine
    UNIVERSIDADE DE SÃO PAULO FACULDADE DE MEDICINA DE RIBEIRÃO PRETO PROGRAMA DE PÓS-GRADUAÇÃO EM IMUNOLOGIA BÁSICA E APLICADA THAIS CRISTINE ARNS Identificação de cascatas gênicas com base na modulação transcricional de células sanguíneas mononucleares periféricas de pacientes com diabetes mellitus do tipo 1 RIBEIRÃO PRETO 2013 THAIS CRISTINE ARNS Identificação de cascatas gênicas com base na modulação transcricional de células sanguíneas mononucleares periféricas de pacientes com diabetes mellitus do tipo 1 Dissertação apresentada à Faculdade de Medicina de Ribeirão Preto da Universidade de São Paulo para obtenção do título de Mestre em Ciências. Área de Concentração: Imunologia Orientador: Prof. Dr. Geraldo Aleixo da Silva Passos Júnior RIBEIRÃO PRETO 2013 AUTORIZO A REPRODUÇÃO E DIVULGAÇÃO TOTAL OU PARCIAL DESTE TRABALHO, POR QUALQUER MEIO CONVENCIONAL OU ELETRÔNICO, PARA FINS DE ESTUDO E PESQUISA, DESDE QUE CITADA A FONTE. FICHA CATALOGRÁFICA Arns, Thais Cristine Identificação de cascatas gênicas com base na modulação transcricional de células sanguíneas mononucleares periféricas de pacientes com diabetes mellitus do tipo 1. Ribeirão Preto, 2013. 159p. Dissertação de Mestrado apresentada à Faculdade de Medicina de Ribeirão Preto da Universidade de São Paulo. Área de concentração: Imunologia. Orientador: Passos, Geraldo Aleixo 1. Diabetes do tipo 1, 2. Microarrays, 3. Gene Set Analysis (GSA), 4. Expressão gênica, 5. Bioinformática. FOLHA DE APROVAÇÃO THAIS CRISTINE ARNS Identificação de cascatas gênicas com base na modulação transcricional de células sanguíneas mononucleares periféricas de pacientes com diabetes mellitus do tipo 1 Dissertação apresentada à Faculdade de Medicina de Ribeirão Preto da Universidade de São Paulo para obtenção do título de Mestre em Ciências. Área de Concentração: Imunologia Aprovado em: __________________ Banca Examinadora Prof.
    [Show full text]
  • Análise Integrativa De Perfis Transcricionais De Pacientes Com
    UNIVERSIDADE DE SÃO PAULO FACULDADE DE MEDICINA DE RIBEIRÃO PRETO PROGRAMA DE PÓS-GRADUAÇÃO EM GENÉTICA ADRIANE FEIJÓ EVANGELISTA Análise integrativa de perfis transcricionais de pacientes com diabetes mellitus tipo 1, tipo 2 e gestacional, comparando-os com manifestações demográficas, clínicas, laboratoriais, fisiopatológicas e terapêuticas Ribeirão Preto – 2012 ADRIANE FEIJÓ EVANGELISTA Análise integrativa de perfis transcricionais de pacientes com diabetes mellitus tipo 1, tipo 2 e gestacional, comparando-os com manifestações demográficas, clínicas, laboratoriais, fisiopatológicas e terapêuticas Tese apresentada à Faculdade de Medicina de Ribeirão Preto da Universidade de São Paulo para obtenção do título de Doutor em Ciências. Área de Concentração: Genética Orientador: Prof. Dr. Eduardo Antonio Donadi Co-orientador: Prof. Dr. Geraldo A. S. Passos Ribeirão Preto – 2012 AUTORIZO A REPRODUÇÃO E DIVULGAÇÃO TOTAL OU PARCIAL DESTE TRABALHO, POR QUALQUER MEIO CONVENCIONAL OU ELETRÔNICO, PARA FINS DE ESTUDO E PESQUISA, DESDE QUE CITADA A FONTE. FICHA CATALOGRÁFICA Evangelista, Adriane Feijó Análise integrativa de perfis transcricionais de pacientes com diabetes mellitus tipo 1, tipo 2 e gestacional, comparando-os com manifestações demográficas, clínicas, laboratoriais, fisiopatológicas e terapêuticas. Ribeirão Preto, 2012 192p. Tese de Doutorado apresentada à Faculdade de Medicina de Ribeirão Preto da Universidade de São Paulo. Área de Concentração: Genética. Orientador: Donadi, Eduardo Antonio Co-orientador: Passos, Geraldo A. 1. Expressão gênica – microarrays 2. Análise bioinformática por module maps 3. Diabetes mellitus tipo 1 4. Diabetes mellitus tipo 2 5. Diabetes mellitus gestacional FOLHA DE APROVAÇÃO ADRIANE FEIJÓ EVANGELISTA Análise integrativa de perfis transcricionais de pacientes com diabetes mellitus tipo 1, tipo 2 e gestacional, comparando-os com manifestações demográficas, clínicas, laboratoriais, fisiopatológicas e terapêuticas.
    [Show full text]
  • Genetics of Type 2 Diabetes: Insights Into the Pathogenesis and Its Clinical Application
    Hindawi Publishing Corporation BioMed Research International Volume 2014, Article ID 926713, 15 pages http://dx.doi.org/10.1155/2014/926713 Review Article Genetics of Type 2 Diabetes: Insights into the Pathogenesis and Its Clinical Application Xue Sun,1 Weihui Yu,2 and Cheng Hu1,3 1 Shanghai Diabetes Institute, Shanghai Clinical Center for Diabetes, Shanghai Key Clinical Center for Metabolic Disease, Shanghai Key Laboratory of Diabetes Mellitus, Shanghai Jiao Tong University Affiliated Sixth People’s Hospital, Shanghai 200233, China 2 Department of Endocrinology and Metabolism, Wenzhou Medical University Affiliated First Hospital, Wenzhou 325000, China 3 Shanghai Jiao Tong University Affiliated Sixth People’s Hospital, South Branch, Shanghai 200233, China Correspondence should be addressed to Cheng Hu; [email protected] Received 7 March 2014; Accepted 22 March 2014; Published 17 April 2014 Academic Editor: Jiarui Wu Copyright © 2014 Xue Sun et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. With rapidly increasing prevalence, diabetes has become one of the major causes of mortality worldwide. According to the latest studies, genetic information makes substantial contributions towards the prediction of diabetes risk and individualized antidiabetic treatment. To date, approximately 70 susceptibility genes have been identified as being associated with type 2 diabetes (T2D) ata −8 genome-wide significant level (<5×10 ). However, all the genetic loci identified so far account for only about 10% of the overall heritability of T2D. In addition, how these novel susceptibility loci correlate with the pathophysiology of the disease remains largely unknown.
    [Show full text]
  • Back Matter (PDF)
    JOBNAME: RNA 12#12 2006 PAGE: 1 OUTPUT: November 10 14:27:49 2006 csh/RNA/125784/reviewers-index RNA: Reviewers for Volume 12, 2006 The editors wish to thank the following individuals whose efforts in reviewing papers for RNA in the past year are greatly appreciated. Juan Alfonzo Donald Burke Fritz Eckstein Carol Greider Frederic Allain John Burke Martin Egli Sam Griffiths-Jones Emily Allen Samuel Butcher Sherif Abou Elela Claudio Gualerzi Sidney Altman Ronald Emeson Alexander Gultyaev Victor Ambros Gail Emilsson Samuel Gunderson Mark Caprara James Anderson Luis Enjuanes Christine Guthrie Paul Anderson Massimo Caputi Anne Ephrussi Raul Andino James Carrington Jay Evans Charles Carter Gordon Hager Mohammed Ararzguioui Eduardo Eyras Paul Hagerman Manuel Ares Richard Carthew Jamie Cate Stephen Hajduk Jean Armengaud Dan Fabris Jean Cavarelli Kathleen Hall Brandon Ason Philip Farabaugh Guillaume Chanfreau Michelle Hamm Gil Ast Jean Feagin Tien-Hsien Chang Scott Hammond Pascal Auffinger Martha Fedor Lawrence Chasin Maureen Hanson Johanna Avis Yuriy Fedorov Chang-Zheng Chen Eoghan Harrington Juli Feigon Eric Christian Michael Harris James Fickett Kristian Baker Christine Clayton Roland Hartmann Carol Fierke Alice Barkan Peter Clote Stephen Harvey Susan Baserga Witold Filipowicz Jeffery Coller Michelle Hastings Brenda Bass Andrew Fire Kathleen Collins Christopher Hayes Christoph Flamm David Bartel Richard Collins Christopher Hellen William Folk Robert Batey Elena Conti Matthias Hentze Maurille Fournier Peter Becker Howard Cooke Thomas Herdegen
    [Show full text]
  • Targeting the Zinc Transporter ZIP7 in the Treatment of Insulin Resistance and Type 2 Diabetes
    nutrients Review Targeting the Zinc Transporter ZIP7 in the Treatment of Insulin Resistance and Type 2 Diabetes John Adulcikas, Sabrina Sonda, Shaghayegh Norouzi, Sukhwinder Singh Sohal and Stephen Myers * College of Health and Medicine, School of Health Sciences, University of Tasmania, TAS 7005, Australia; [email protected] (J.A.); [email protected] (S.S.); [email protected] (S.N.); [email protected] (S.S.S.) * Correspondence: [email protected]; Tel.: +61-3-6324-5459 Received: 20 December 2018; Accepted: 12 February 2019; Published: 15 February 2019 Abstract: Type 2 diabetes mellitus (T2DM) is a disease associated with dysfunctional metabolic processes that lead to abnormally high levels of blood glucose. Preceding the development of T2DM is insulin resistance (IR), a disorder associated with suppressed or delayed responses to insulin. The effects of this response are predominately mediated through aberrant cell signalling processes and compromised glucose uptake into peripheral tissue including adipose, liver and skeletal muscle. Moreover, a major factor considered to be the cause of IR is endoplasmic reticulum (ER) stress. This subcellular organelle plays a pivotal role in protein folding and processes that increase ER stress, leads to maladaptive responses that result in cell death. Recently, zinc and the proteins that transport this metal ion have been implicated in the ER stress response. Specifically, the ER-specific zinc transporter ZIP7, coined the “gate-keeper” of zinc release from the ER into the cytosol, was shown to be essential for maintaining ER homeostasis in intestinal epithelium and myeloid leukaemia cells. Moreover, ZIP7 controls essential cell signalling pathways similar to insulin and activates glucose uptake in skeletal muscle.
    [Show full text]
  • The Effect of Acid on the Dynamics of Intracellular Zinc and the Marker Expressions Of
    The Effect of Acid on the Dynamics of Intracellular Zinc and the Marker Expressions of Pluripotency in Somatic Cells A thesis presented to the faculty of the College of Arts and Sciences of Ohio University In partial fulfillment of the requirements for the degree Master of Science Yuli Hu April 2021 © 2021 Yuli Hu. All Rights Reserved. 2 This thesis titled The Effect of Acid on the Dynamics of Intracellular Zinc and the Marker Expressions of Pluripotency in Somatic Cells by YULI HU has been approved for the Department of Biological Sciences and the College of Arts and Sciences by Yang V. Li Professor of Biomedical Sciences Florenz Plassmann Dean, College of Arts and Sciences 3 Abstract YULI HU, M.S., April 2021, Biological Sciences The Effect of Acid on the Dynamics of Intracellular Zinc and the Marker Expressions of Pluripotency in Somatic Cells Director of Thesis: Yang V. Li Microenvironmental pH is one of the factors that affect the stability of zinc- protein binding. The tight binding between zinc and proteins is favored by the basic pH, whereas acidic pH favors a loose bound, and treatment of strong acid results in the dissociation of zinc. Physiologically, the stomach uses a very acidic pH to digest food which results in a high amount of soluble zinc in the stomach. Whether or not zinc co- present with acid and the effect of zinc on the gastric lining has rarely been discussed. In my experiments, acidic treatment induced the expression of a pluripotent marker in primary cultured gastric cells. It also stimulated the release of intracellular zinc, suggesting that acidic pH supported protein expression through dynamic zinc regulation.
    [Show full text]
  • Transporters
    Alexander, S. P. H., Kelly, E., Mathie, A., Peters, J. A., Veale, E. L., Armstrong, J. F., Faccenda, E., Harding, S. D., Pawson, A. J., Sharman, J. L., Southan, C., Davies, J. A., & CGTP Collaborators (2019). The Concise Guide to Pharmacology 2019/20: Transporters. British Journal of Pharmacology, 176(S1), S397-S493. https://doi.org/10.1111/bph.14753 Publisher's PDF, also known as Version of record License (if available): CC BY Link to published version (if available): 10.1111/bph.14753 Link to publication record in Explore Bristol Research PDF-document This is the final published version of the article (version of record). It first appeared online via Wiley at https://bpspubs.onlinelibrary.wiley.com/doi/full/10.1111/bph.14753. Please refer to any applicable terms of use of the publisher. University of Bristol - Explore Bristol Research General rights This document is made available in accordance with publisher policies. Please cite only the published version using the reference above. Full terms of use are available: http://www.bristol.ac.uk/red/research-policy/pure/user-guides/ebr-terms/ S.P.H. Alexander et al. The Concise Guide to PHARMACOLOGY 2019/20: Transporters. British Journal of Pharmacology (2019) 176, S397–S493 THE CONCISE GUIDE TO PHARMACOLOGY 2019/20: Transporters Stephen PH Alexander1 , Eamonn Kelly2, Alistair Mathie3 ,JohnAPeters4 , Emma L Veale3 , Jane F Armstrong5 , Elena Faccenda5 ,SimonDHarding5 ,AdamJPawson5 , Joanna L Sharman5 , Christopher Southan5 , Jamie A Davies5 and CGTP Collaborators 1School of Life Sciences,
    [Show full text]
  • The International Journal of Developmental Biology
    Int. J. Dev. Biol. 53: 725-731 (2009) DEVELOPMENTALTHE INTERNATIONAL JOURNAL OF doi: 10.1387/ijdb.072575mr BIOLOGY www.intjdevbiol.com Molecular tools, classic questions - an interview with Clifford Tabin MICHAEL K. RICHARDSON* Institute of Biology, Leiden University, Leiden, The Netherlands ABSTRACT Clifford J. Tabin has made pioneering contributions to several fields in biology, including retroviruses, oncogenes, developmental biology and evolution. His father, a physicist who worked in the Manhattan project, kindled his interest in science. Cliff later chose to study biology and started his research career when the world of recombinant DNA was opening up. In Robert Weinberg’s lab, he constructed the Moloney leukaemia virus (MLV-tk), the first recombi- nant retrovirus that could be used as a eukaryotic vector. He also discovered the amino acid changes leading to the activation of Ras, the first human oncogene discovered. As an independent researcher, he began in the field of urodele limb regeneration, and described the expression of retinoic acid receptor and Hox genes in the blastema. Moving to the chick model, his was one of the labs that simultaneously cloned the first vertebrate hedgehog cognates and showed that sonic hedgehog functions as a morphogen in certain developmental contexts, in particular as an organizing activity during limb development. Comparative studies by Ann Burke in his lab showed that differences in boundaries of Hox gene expression across vertebrate phylogeny correlated with differences in skeletal morphology. The Tabin lab also discovered a genetic pathway responsible for mediating left-right asymmetry in vertebrates; helped uncover the pathways leading to dorsoventral limb patterning; made contributions to our understanding of skeletal morphogenesis and identified developmental mechanisms that might underpin the diversifica- tion of the beak in Darwin’s finches.
    [Show full text]
  • New Mesh Headings for 2018 Single Column After Cutover
    New MeSH Headings for 2018 Listed in alphabetical order with Heading, Scope Note, Annotation (AN), and Tree Locations 2-Hydroxypropyl-beta-cyclodextrin Derivative of beta-cyclodextrin that is used as an excipient for steroid drugs and as a lipid chelator. Tree locations: beta-Cyclodextrins D04.345.103.333.500 D09.301.915.400.375.333.500 D09.698.365.855.400.375.333.500 AAA Domain An approximately 250 amino acid domain common to AAA ATPases and AAA Proteins. It consists of a highly conserved N-terminal P-Loop ATPase subdomain with an alpha-beta-alpha conformation, and a less-conserved C- terminal subdomain with an all alpha conformation. The N-terminal subdomain includes Walker A and Walker B motifs which function in ATP binding and hydrolysis. Tree locations: Amino Acid Motifs G02.111.570.820.709.275.500.913 AAA Proteins A large, highly conserved and functionally diverse superfamily of NTPases and nucleotide-binding proteins that are characterized by a conserved 200 to 250 amino acid nucleotide-binding and catalytic domain, the AAA+ module. They assemble into hexameric ring complexes that function in the energy-dependent remodeling of macromolecules. Members include ATPASES ASSOCIATED WITH DIVERSE CELLULAR ACTIVITIES. Tree locations: Acid Anhydride Hydrolases D08.811.277.040.013 Carrier Proteins D12.776.157.025 Abuse-Deterrent Formulations Drug formulations or delivery systems intended to discourage the abuse of CONTROLLED SUBSTANCES. These may include physical barriers to prevent chewing or crushing the drug; chemical barriers that prevent extraction of psychoactive ingredients; agonist-antagonist combinations to reduce euphoria associated with abuse; aversion, where controlled substances are combined with others that will produce an unpleasant effect if the patient manipulates the dosage form or exceeds the recommended dose; delivery systems that are resistant to abuse such as implants; or combinations of these methods.
    [Show full text]
  • Supplemental Data
    Article TCF7L2 is a master regulator of insulin production and processing ZHOU, Yuedan, et al. Abstract Genome-wide association studies have revealed >60 loci associated with type 2 diabetes (T2D), but the underlying causal variants and functional mechanisms remain largely elusive. Although variants in TCF7L2 confer the strongest risk of T2D among common variants by presumed effects on islet function, the molecular mechanisms are not yet well understood. Using RNA-sequencing, we have identified a TCF7L2-regulated transcriptional network responsible for its effect on insulin secretion in rodent and human pancreatic islets. ISL1 is a primary target of TCF7L2 and regulates proinsulin production and processing via MAFA, PDX1, NKX6.1, PCSK1, PCSK2 and SLC30A8, thereby providing evidence for a coordinated regulation of insulin production and processing. The risk T-allele of rs7903146 was associated with increased TCF7L2 expression, and decreased insulin content and secretion. Using gene expression profiles of 66 human pancreatic islets donors', we also show that the identified TCF7L2-ISL1 transcriptional network is regulated in a genotype-dependent manner. Taken together, these results demonstrate that not only synthesis of [...] Reference ZHOU, Yuedan, et al. TCF7L2 is a master regulator of insulin production and processing. Human Molecular Genetics, 2014, vol. 23, no. 24, p. 6419-6431 DOI : 10.1093/hmg/ddu359 PMID : 25015099 Available at: http://archive-ouverte.unige.ch/unige:45177 Disclaimer: layout of this document may differ from the published
    [Show full text]